AFIB (Acutus Medical) Piotroski F-Score: 0 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acutus Medical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acutus Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Acutus Medical's Piotroski F-Score or its related term are showing as below:

Acutus Medical  (OTCPK:AFIB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Acutus Medical Piotroski F-Score Related Terms


Acutus Medical Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Acutus Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acutus Medical Piotroski F-Score Chart

Acutus Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial 5.00 5.00 2.00 3.00 3.00

Acutus Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 2.00 2.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was -1.62 + -0.914 + -5.607 + -1.406 = $-9.55 Mil.
Cash Flow from Operations was -16.929 + -6.975 + -3.698 + -4.058 = $-31.66 Mil.
Revenue was 3.625 + 4.127 + 5.266 + 7.13 = $20.15 Mil.
Gross Profit was -0.03 + -0.343 + 0.372 + 1.005 = $1.00 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(53.96 + 41.668 + 35.474 + 32.167 + 28.648) / 5 = $38.3834 Mil.
Total Assets at the begining of this year (Dec23) was $53.96 Mil.
Long-Term Debt & Capital Lease Obligation was $27.80 Mil.
Total Current Assets was $25.58 Mil.
Total Current Liabilities was $12.44 Mil.
Net Income was -16.315 + -18.346 + -13.237 + -33.765 = $-81.66 Mil.

Revenue was 1.242 + 1.515 + 2.06 + 2.348 = $7.17 Mil.
Gross Profit was -0.869 + -1.012 + -1.09 + -0.118 = $-3.09 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(133.44 + 115.996 + 100.295 + 84.728 + 53.96) / 5 = $97.6838 Mil.
Total Assets at the begining of last year (Dec22) was $133.44 Mil.
Long-Term Debt & Capital Lease Obligation was $35.90 Mil.
Total Current Assets was $46.25 Mil.
Total Current Liabilities was $18.94 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acutus Medical's current Net Income (TTM) was -9.55. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acutus Medical's current Cash Flow from Operations (TTM) was -31.66. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-9.547/53.96
=-0.17692735

ROA (Last Year)=Net Income/Total Assets (Dec22)
=-81.663/133.44
=-0.61198291

Acutus Medical's return on assets of this year was -0.17692735. Acutus Medical's return on assets of last year was -0.61198291. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Acutus Medical's current Net Income (TTM) was -9.55. Acutus Medical's current Cash Flow from Operations (TTM) was -31.66. ==> -31.66 <= -9.55 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=27.802/38.3834
=0.72432354

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=35.897/97.6838
=0.36748161

Acutus Medical's gearing of this year was 0.72432354. Acutus Medical's gearing of last year was 0.36748161. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=25.578/12.438
=2.05643994

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=46.252/18.942
=2.44176961

Acutus Medical's current ratio of this year was 2.05643994. Acutus Medical's current ratio of last year was 2.44176961. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Acutus Medical's number of shares in issue this year was 29.768. Acutus Medical's number of shares in issue last year was 29.308. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1.004/20.148
=0.04983125

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-3.089/7.165
=-0.43112352

Acutus Medical's gross margin of this year was 0.04983125. Acutus Medical's gross margin of last year was -0.43112352. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=20.148/53.96
=0.37338769

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=7.165/133.44
=0.05369454

Acutus Medical's asset turnover of this year was 0.37338769. Acutus Medical's asset turnover of last year was 0.05369454. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acutus Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.


Acutus Medical Business Description

Address 2210 Faraday Avenue, Suite 100, Carlsbad, CA, USA, 92008
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products world-wide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.